117 related articles for article (PubMed ID: 10987990)
61. Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease.
Martín Giménez VM; Noriega SE; Kassuha DE; Fuentes LB; Manucha W
Ther Adv Cardiovasc Dis; 2018 Jul; 12(7):177-190. PubMed ID: 29764302
[TBL] [Abstract][Full Text] [Related]
62. Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal.
Pryor SR
Med Hypotheses; 2000 Dec; 55(6):494-501. PubMed ID: 11090297
[TBL] [Abstract][Full Text] [Related]
63. Mechanisms of human eosinophil migration induced by the combination of IL-5 and the endocannabinoid 2-arachidonoyl-glycerol.
Larose MC; Turcotte C; Chouinard F; Ferland C; Martin C; Provost V; Laviolette M; Flamand N
J Allergy Clin Immunol; 2014 May; 133(5):1480-2, 1482.e1-3. PubMed ID: 24530098
[No Abstract] [Full Text] [Related]
64. Opioid induction of immunoreactive interleukin-1 in Mytilus edulis and human immunocytes: an interleukin-1-like substance in invertebrate neural tissue.
Stefano GB; Smith EM; Hughes TK
J Neuroimmunol; 1991 Apr; 32(1):29-34. PubMed ID: 2002089
[TBL] [Abstract][Full Text] [Related]
65. The biochemical substrate of nitric oxide signaling is present in primitive non-cognitive organisms.
Stefano GB; Ottaviani E
Brain Res; 2002 Jan; 924(1):82-9. PubMed ID: 11743998
[TBL] [Abstract][Full Text] [Related]
66. Do N-arachidonyl-glycine (NA-glycine) and 2-arachidonoyl glycerol (2-AG) share mode of action and the binding site on the β2 subunit of GABAA receptors?
Baur R; Gertsch J; Sigel E
PeerJ; 2013; 1():e149. PubMed ID: 24058880
[TBL] [Abstract][Full Text] [Related]
67. 2-arachidonoylglycerol: a possible multifunctional lipid mediator in the nervous and immune systems.
Sugiura T; Waku K
Ann N Y Acad Sci; 2000 Apr; 905():344-6. PubMed ID: 10818479
[No Abstract] [Full Text] [Related]
68. The dual role of cannabidiol on monocyte-derived dendritic cell differentiation and maturation.
Pénzes Z; Alimohammadi S; Horváth D; Oláh A; Tóth BI; Bácsi A; Szöllősi AG
Front Immunol; 2023; 14():1240800. PubMed ID: 37680639
[TBL] [Abstract][Full Text] [Related]
69. The Endocannabinoid System in the Mediterranean Mussel
Mosca F; Zarivi O; Battista N; Maccarrone M; Tiscar PG
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066927
[TBL] [Abstract][Full Text] [Related]
70. Endocannabinoids in immune regulation and immunopathologies.
Rahaman O; Ganguly D
Immunology; 2021 Oct; 164(2):242-252. PubMed ID: 34053085
[TBL] [Abstract][Full Text] [Related]
71. CannabinEYEds: The Endocannabinoid System as a Regulator of the Ocular Surface Nociception, Inflammatory Response, Neovascularization and Wound Healing.
Aiello F; Gallo Afflitto G; Li JO; Martucci A; Cesareo M; Nucci C
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33327429
[TBL] [Abstract][Full Text] [Related]
72. In Vivo Targeted Metabolomic Profiling of Prostanit, a Novel Anti-PAD NO-Donating Alprostadil-Based Drug.
Shestakova KM; Moskaleva NE; Mesonzhnik NV; Kukharenko AV; Serkov IV; Lyubimov II; Fomina-Ageeva EV; Bezuglov VV; Akimov MG; Appolonova SA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322104
[TBL] [Abstract][Full Text] [Related]
73. Opposite Effects of Neuroprotective Cannabinoids, Palmitoylethanolamide, and 2-Arachidonoylglycerol on Function and Morphology of Microglia.
Hohmann U; Pelzer M; Kleine J; Hohmann T; Ghadban C; Dehghani F
Front Neurosci; 2019; 13():1180. PubMed ID: 31787870
[TBL] [Abstract][Full Text] [Related]
74. The endocannabinoid system: 'NO' longer anonymous in the control of nitrergic signalling?
Lipina C; Hundal HS
J Mol Cell Biol; 2017 Apr; 9(2):91-103. PubMed ID: 28130308
[TBL] [Abstract][Full Text] [Related]
75. Endocannabinoid signalling in innate and adaptive immunity.
Chiurchiù V; Battistini L; Maccarrone M
Immunology; 2015 Mar; 144(3):352-364. PubMed ID: 25585882
[TBL] [Abstract][Full Text] [Related]
76. Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.
Stanley CP; O'Sullivan SE
Pharmacol Res; 2014 Mar; 81(100):74-82. PubMed ID: 24548820
[TBL] [Abstract][Full Text] [Related]
77. Vascular targets for cannabinoids: animal and human studies.
Stanley C; O'Sullivan SE
Br J Pharmacol; 2014 Mar; 171(6):1361-78. PubMed ID: 24329566
[TBL] [Abstract][Full Text] [Related]
78. 2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.
Chouinard F; Turcotte C; Guan X; Larose MC; Poirier S; Bouchard L; Provost V; Flamand L; Grandvaux N; Flamand N
J Leukoc Biol; 2013 Feb; 93(2):267-76. PubMed ID: 23242611
[TBL] [Abstract][Full Text] [Related]
79. Update on the role of cannabinoid receptors after ischemic stroke.
Capettini LS; Savergnini SQ; da Silva RF; Stergiopulos N; Santos RA; Mach F; Montecucco F
Mediators Inflamm; 2012; 2012():824093. PubMed ID: 22577257
[TBL] [Abstract][Full Text] [Related]
80. Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?
Malinowska B; Baranowska-Kuczko M; Schlicker E
Br J Pharmacol; 2012 Apr; 165(7):2073-88. PubMed ID: 22022923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
